Key result
Age ≥60 years linked to ~89% lower odds of acetylcholine-induced coronary spasm in ANOCA.
Why the study?
Does a 3-variable clinical and physiological prediction model (age ≥ 60 years, dyslipidaemia, and IMR ≥ 25) accurately predict acetylcholine-induced coronary spasm and reduce unnecessary testing in patients with ANOCA/INOCA?
Cohort (n=47)
No
Does a 3-variable clinical and physiological prediction model (age ≥ 60 years, dyslipidaemia, and IMR ≥ 25) accurately predict acetylcholine-induced coronary spasm and reduce unnecessary testing in patients with ANOCA/INOCA?
In ANOCA/INOCA patients, older age (≥60 years) and dyslipidaemia are independently associated with lower odds of acetylcholine-induced coronary spasm, and an exploratory model combining these with IMR ≥ 25 showed good discrimination (AUC 0.83) to potentially reduce unnecessary invasive vasoreactivity testing.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for triaging invasive spasm testing in ANOCA/INOCA and should not yet change practice; leaves open prospective external validation beyond this 47-patient cohort.
BACKGROUND: A substantial proportion of patients with angina and/or ischemia are found to have non-obstructive coronary arteries (ANOCA/INOCA). Their symptoms can sometimes be explained by coronary microvascular dysfunction and/or vasospasm. Selecting patients for acetylcholine testing remains challenging, and the procedure is not trivial in terms of logistics, cost, and risk. AIMS: The aim of this single-center retrospective study was to identify predictors of coronary spasm and define features that may help avoid unnecessary testing. METHODS: All consecutive ANOCA/INOCA patients who underwent intracoronary acetylcholine testing between February 2022 and June 2025 at a tertiary university hospital were included. Baseline clinical variables were analyzed using multivariable logistic regression. A 3-variable exploratory model was then constructed to identify independent predictors of unnecessary acetylcholine testing. RESULTS: Among the study population (n = 47), 46.8% demonstrated a positive spasm response. In the multivariable model, age ≥ 60 years (OR = 0.11, 95% CI [0.02-0.80]; p = 0.029) and dyslipidaemia (OR = 0.12, 95% CI [0.01-0.99]; p = 0.049) were independently associated with lower odds of spasm, whereas IMR ≥ 25 showed a non-significant association with lower odds of spasm (OR = 0.10, 95% CI [0.005-1.9]; p = 0.128). The 3-variable exploratory model showed good discrimination (AUC 0.83, 95% CI 0.68-0.97) and was associated with a reduction in overall ACh testing by 45.2% in complete-case analysis, with a sensitivity of 85.7%. CONCLUSIONS: Dyslipidaemia and age ≥ 60 years are independently associated with lower odds of acetylcholine-induced spasm. This model showed good discrimination and may help inform strategies to reduce unnecessary acetylcholine testing, although these findings require external validation.
No takes yet. Share an insight, caveat, or question.
Buri et al. (2026) conducted a cohort in Angina or ischemia with non-obstructive coronary arteries (ANOCA/INOCA) (n=47). Age ≥ 60 years (with dyslipidaemia and IMR ≥ 25 in a 3-variable exploratory model) vs. Age < 60 years was evaluated on Acetylcholine-induced coronary spasm (epicardial or microvascular spasm according to COVADIS criteria) (OR 0.11, 95% CI 0.02-0.80, p=0.029). Age ≥ 60 years and dyslipidaemia were independently associated with lower odds of acetylcholine-induced coronary spasm in ANOCA/INOCA patients.
Synapse has enriched 10 related papers. Consider them for comparative context: